Extramedullary manifestations of myeloid neoplasms
CS Wilson, LJ Medeiros - American Journal of Clinical …, 2015 - academic.oup.com
Objectives: This session of the 2013 Society of Hematopathology/European Association for
Haematopathology workshop focused on extramedullary manifestations of myeloid …
Haematopathology workshop focused on extramedullary manifestations of myeloid …
Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey
Abstract Introduction Myeloid Sarcoma (MS) is a rare hematologic myeloid neoplasm that
can involve any site of the body. It can occur as an exclusively extramedullary form or it can …
can involve any site of the body. It can occur as an exclusively extramedullary form or it can …
Clinicopathological and molecular characteristics of extramedullary acute myeloid leukaemia
DI Ullman, D Dorn, JA Jones, D Fasciano… - …, 2019 - Wiley Online Library
Aims Myeloid sarcoma (MS) is a rare extramedullary neoplasm composed of immature
myeloid precursor cells thought to be a unique clinical presentation of acute myeloid …
myeloid precursor cells thought to be a unique clinical presentation of acute myeloid …
Clinical and molecular characterization of myeloid sarcoma without medullary leukemia
HA Abbas, PK Reville, A Geppner… - Leukemia & …, 2021 - Taylor & Francis
Myeloid sarcoma (MS) in the setting of concomitant medullary AML is relatively well
described, while much less is known about patients presenting with MS with< 20% bone …
described, while much less is known about patients presenting with MS with< 20% bone …
Myeloid sarcoma: extramedullary manifestation of myeloid disorders
C Campidelli, C Agostinelli, R Stitson… - American journal of …, 2009 - academic.oup.com
Myeloid sarcoma (MS), also termed extramedullary acute myeloid leukemia, extramedullary
myeloid tumor, and granulocytic sarcoma or chloroma, is a rare manifestation that is …
myeloid tumor, and granulocytic sarcoma or chloroma, is a rare manifestation that is …
[HTML][HTML] Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: a single-institution experience
JY Lee, H Chung, H Cho, JE Jang, Y Kim, SJ Kim… - Blood …, 2017 - ncbi.nlm.nih.gov
Background Isolated myeloid sarcoma (MS) is a rare extramedullary tumor mass composed
of malignant myeloid precursor cells without any evidence of leukemia in the peripheral …
of malignant myeloid precursor cells without any evidence of leukemia in the peripheral …
Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years
Background: Myeloid sarcoma (MS) is characterized by extramedullary infiltration by
immature myeloid cells. Owing to rarity of this disease, the clinical features and overall …
immature myeloid cells. Owing to rarity of this disease, the clinical features and overall …
[HTML][HTML] Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set
G Goyal, AC Bartley, MM Patnaik, MR Litzow… - Blood cancer …, 2017 - nature.com
Extramedullary myeloid sarcoma (MS, also known as granulocytic sarcoma, myeloblastoma
or chloroma) is a rare form (o1%) of extramedullary acute myeloid leukemia (AML) …
or chloroma) is a rare form (o1%) of extramedullary acute myeloid leukemia (AML) …
Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation
Y Koc, KB Miller, DP Schenkein… - … Journal of the …, 1999 - Wiley Online Library
BACKGROUND Extramedullary tumors of lymphoid and myeloid blasts outside the well‐
defined sanctuaries following allogeneic bone marrow transplantation (allo‐BMT) are rare …
defined sanctuaries following allogeneic bone marrow transplantation (allo‐BMT) are rare …
Presentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis
Isolated myeloid sarcoma (MS) is a rare extramedullary presentation of acute myeloid
leukemia (AML). Little is known about MS outcomes due to its rarity. A population-based …
leukemia (AML). Little is known about MS outcomes due to its rarity. A population-based …